4//SEC Filing
MARSHBANKS TRACY 4
Accession 0001144204-18-021409
CIK 0001023024other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 6:33 PM ET
Size
5.7 KB
Accession
0001144204-18-021409
Insider Transaction Report
Form 4
MARSHBANKS TRACY
Director
Transactions
- Sale
Common Stock
2018-04-18$62.09/sh−33,200$2,061,388→ 450,601 total(indirect: See Footnote)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $62.00 to $62.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Held by FA Private Equity Fund IV, L.P., FA Private Equity Fund IV GmbH & Co. Beteiligungs KG, The Productivity Fund IV Liquidating Trust, and The Productivity Fund IV Advisors Fund Liquidating Trust, which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001579618
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 6:33 PM ET
- Size
- 5.7 KB